PharmaShots

MARCH 24, 2023

PTC Therapeutics’ Upstaza (eladocagene exuparvovec) Receives NICE Recommendation for the Treatment of AADC Deficiency Date: Mar 24, 2023 | Tags: PTC Therapeutics, Upstaza, eladocagene exuparvovec, AADC Deficiency, Regulatory, NICE Onconova Therapeutics Entered into a Research Collaboration with Pangea Biomed to Identify Biomarkers for Cancer (..)

FDA 40

FDA Immunization 40

PharmaShots

FEBRUARY 24, 2023

Positive Solid Tumors Date: Feb 23, 2023 | Tags: Keymed, Lepu Biopharma, AstraZeneca, CMG901, Claudin 18.2-Positive Positive Solid Tumors Date: Feb 23, 2023 | Tags: Keymed, Lepu Biopharma, AstraZeneca, CMG901, Claudin 18.2-Positive Positive Solid Tumors Date: Feb 23, 2023 | Tags: Keymed, Lepu Biopharma, AstraZeneca, CMG901, Claudin 18.2-Positive

FDA 40

FDA Vaccines 40

PharmaShots

FEBRUARY 3, 2023

4D Molecular Therapeutics Receives the US FDA’s IND Clearance of 4D-150 for the Treatment of Diabetic Macular Edema Date: Feb 03, 2023 | Tags: 4D Molecular Therapeutics, 4D-150, Diabetic Macular Edema, Regulatory, US, FDA, IND AstraZeneca and Amgen Receive the US FDA’s Approval of Tezspire (tezepelumab) for the Treatment of Severe Asthma (..)

FDA 40

FDA Labelling 40

Pharmaceutical Technology

MAY 1, 2023

Under the deal terms, Shunxi will have licence to develop, manufacture, and commercialise CTH-004 to treat several solid tumours including ovarian cancer in Greater China, including Hong Kong, Taiwan, Mainland China, and Macao. Shunxi will also hold an option to negotiate rights to other CAR-T products, which include the licenced IP.

52

52

Viseven

MAY 24, 2023

During her speech, Viseven CEO Nataliya Andreychuk, emphasized the importance of content marketing in pharma and the related software tools and techniques, such as tagging for better navigation, content reuse with modules, and overall production optimization. The post Viseven at Reuters Pharma EU appeared first on Viseven.

Customer Service 52

Customer Service Communication 52

Roots Analysis

MARCH 1, 2024

Examples of such technologies include DNA Taggants (a unique DNA tag used in the product / packaging that can be scanned using a designated instrument / equipment), invisible printing technologies, digital watermark technologies and hidden markers / print technologies.

Packaging 52

Packaging Labelling 52

pharmaphorum

JANUARY 5, 2022

Novartis’ Tepmetko (tepotinib) was approved b the FDA last year for both treatment naïve and previously treated METex14 positive NSCLC patients, as was Merck’s Tabrecta (capmatinib), while Hutchmed’s Orpathys (savolitinib) has been approved as a second-line option in China.

FDA 109

FDA Chemotherapy 109

Pharmaceutical Technology

DECEMBER 15, 2022

The US is set to dominate the cardiomyopathy landscape because of the country’s high prevalence of dilated cardiomyopathy (DCM) relative to the other markets in the 7MM, as well as the higher price tag on US-marketed therapeutics. The second highest contributing market is APAC, generating 33.2%

52

52

Pharmaceutical Technology

DECEMBER 5, 2022

Collectively, cannabinoid receptors (CB1 and CB2) are currently the most popular targets in preclinical stage of development, with 391 drugs tagged in total. This is closely followed by CB2 receptors in second place. This is followed by epilepsy at 8% of the pipeline and multiple sclerosis at 7% of the pipeline.

Controlled Substances 98

Controlled Substances Compounding Immunization 98

Pharmaceutical Technology

MAY 2, 2023

High-prescribing physicians surveyed by GlobalData across eight major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and China) identified a broad range of unmet needs in the IO space (see Figure 1). Despite the significant advances that have been made in the IO field, a huge level of unmet need remains.

Immunization 52

Immunization Vaccines 52

pharmaphorum

NOVEMBER 27, 2022

In recent years, the UK pharmaceutical industry has relied heavily on China and India as providers of active pharmaceutical ingredients. Here’s how applying automaton in pharmaceutical labs can help address these. Reducing capacity issues.

Communication 100

Communication Pharmaceutical Companies Pharmaceutical Companies Packaging 100

pharmaphorum

MARCH 27, 2022

Carvykti – developed by J&J with China’s Legend Biotech – was approved on the back of a single arm, open-label, clinical trial in 113 patients – CARTITUDE-1 – which showed an overall response rate of 84%, with signs of the cancer disappearing altogether in 69% of recipients.

Labelling 81

Labelling Immunization FDA 81

pharmaphorum

NOVEMBER 19, 2021

Meanwhile, China and Russia have rolled out state-owned vaccines. Indeed, the price tags for Pfizer’s and Moderna’s jabs are substantial. Meanwhile, China and Russia have struck deals for their jabs, although sales figures have not been revealed. Pfizer/BioNTech’s vaccine dominates the market. billion and Pfizer predicts $33.5

Vaccines 126

Vaccines Communication 126

pharmaphorum

FEBRUARY 26, 2021

It was also during this time that J&J opened the first operating companies in China and Egypt. For all the latest pharma news on Johnson & Johnson, follow pharmaphorum’s J&J and Janssen tags. During this tenure, J&J entered into the areas of vision care, mechanical wound closure and diabetes management.

Vaccines 113

Vaccines Labelling Communication 113

Pharmaceutical Technology

MARCH 17, 2023

In some cases, she said, “[drug] innovation would have been otherwise hindered by their price tag alone”. Watt explained that for newer, first-in-class drugs these types of agreements can also give healthcare systems safety in their decisions to approve certain drugs. Click here to watch this webinar and access the presentation.

Pharmaceutical Companies 102

Pharmaceutical Companies Pharmaceutical Companies Communication 102

Pharmaceutical Technology

NOVEMBER 30, 2022

The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. Taiwan, Province of China. Novo Nordisk is another company leading the charge in this field. compared to a 5.1% reduction for people treated with semaglutide. Cape Verde.

Insurance 105

Insurance Labelling Communication FDA 105

Pharmaceutical Technology

NOVEMBER 30, 2022

The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. Taiwan, Province of China. Novo Nordisk is another company leading the charge in this field. compared to a 5.1% reduction for people treated with semaglutide. Cape Verde.

Insurance 98

Insurance Labelling Communication FDA 98